Th1/IFNγ gene signature in the tumor microenvironment has been regarded as an independent biomarker to predict the prognosis of resectable high-risk melanoma patients.352 Moreover, the status of IFN-γ is associated with the response or resistance to immunotherapy. The gene discussed is IFNG; the disease is neoplasm.